1,011 results on '"Meltzer, H. Y."'
Search Results
2. Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample
3. Psychotic Continuum or Distinct Entities: Perspective from Psychopharmacology
4. Role of the Serotonergic System in Pituitary Hormone Secretion: The Pharmacologic Challenge Paradigm in Man
5. Serotonin Receptors and Antipsychotic Drug Action
6. The Effect of Clozapine and Other Atypical Antipsychotic Drugs on Negative Symptoms
7. Serotonin Agonist Induced Corticosterone and Prolactin Secretion: Role of 5-HT2 and 5-HT1A Receptors
8. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene
9. The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia
10. Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia
11. The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats
12. Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
13. Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis
14. Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant
15. Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis
16. Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients
17. The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine
18. Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia
19. Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: Role of indirect 5-HT1A partial agonism
20. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia
21. A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia
22. An atypical compound by any other name is still a....
23. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain
24. Analysis of genome-wide CAG/CTG repeats, and at SEF2-1B and ERDA1 in schizophrenia and bipolar affective disorder
25. The role of serotonin receptors in the action of atypical antipsychotic drugs
26. Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia
27. Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine
28. Effect of pindolol on hormone secretion and body temperature: Partial agonist effects
29. D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs
30. Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression
31. CREATINE KINASE LEVELS AS A PUTATIVE PERIPHERAL NEUROCHEMICAL MARKER OF NEUROLEPTICS-RELATED MYOTOXICITY: P.102
32. Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims
33. Buspirone does not produce a 5-HT1A-mediated decrease in temperature in man
34. Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients
35. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers
36. The Relationship Between Smooth Pursuit Performance, Motion Perception and Sustained Visual Attention in Patients with Schizophrenia and Normal Controls
37. Pre-morbid Asociality in Neuroleptic-resistant and Neuroleptic-responsive Schizophrenia
38. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs
39. Abnormal serotonergic stimulation of cortisol production in obstructive sleep apnea.
40. Smooth Pursuit Performance in Patients With Affective Disorders or Schizophrenia and Normal Controls: Analysis With Specific Oculomotor Measures, RMS Error and Qualitative Ratings
41. Erratum: The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia
42. Distribution and pharmacology of the enkephalins
43. Serotonin and Mood: Neuroendocrine Aspects
44. Negative Symptoms in Schizophrenia: A Target for New Drug Development
45. Effect of Neuroleptics on the Schizophrenic Syndrome
46. Biological Studies of the Nosology of the Major Psychoses: A Status Report on the Schizoaffective Disorders
47. A Biochemical and Neuroendocrine Study of the Serotonergic System in Depression
48. Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia
49. Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion
50. Effect of d- and l-amphetamine on rat plasma prolactin levels
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.